• 1
    Weinblatt ME, Keystone EC, Furst DE, et al . Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. Arthritis Rheum. 2000; 48: 3545.
  • 2
    Burmester GR, Mariette X, Montecucco C, et al . Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial. Ann Rheum Dis. 2007; 66: 7329.
  • 3
    Weinblatt ME, Kremer JM, Bankhurst AD, et al . A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med. 1999; 340: 2539.
  • 4
    Elliott MJ, Maini RN, Feldmann M, et al . Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet. 1994; 344: 110510.
  • 5
    Emery P, Fleischmann RM, Moreland LW, et al . Golimumab, a human anti-tumor necrosis factor alpha monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: twenty-four-week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis. Arthritis Rheum. 2009; 60: 227283.
  • 6
    Badot V, Galant C, Nzeusseu Toukap A, et al . Gene expression profiling in the synovium identifies a predictive signature of absence of response to adalimumab therapy in rheumatoid arthritis. Arthritis Res Ther. 2009; 11: R57.
  • 7
    Goodwin RG, Friend D, Ziegler SF, et al . Cloning of the human and murine interleukin-7 receptors: demonstration of a soluble form and homology to a new receptor superfamily. Cell. 1990; 60: 94151.
  • 8
    Pleiman CM, Gimpel SD, Park LS, et al . Organization of the murine and human interleukin-7 receptor genes: two mRNAs generated by differential splicing and presence of a type I-interferon-inducible promoter. Mol Cell Biol. 1991; 11: 30529.
  • 9
    Arnett FC, Edworthy SM, Bloch DA, et al . The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988; 31: 31524.
  • 10
    van Gestel AM, Prevoo ML, van ‘t Hof MA, et al . Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum. 1996; 39: 3440.
  • 11
    De Bari C, Dell’Accio F, Tylzanowski P, et al . Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum. 2001; 44: 192842.
  • 12
    Nzeusseu Toukap A, Galant C, Theate I, et al . Identification of distinct gene expression profiles in the synovium of patients with systemic lupus erythematosus. Arthritis Rheum. 2007; 56: 157988.
  • 13
    Liu X, Leung S, Wang C, et al . Crucial role of interleukin-7 in T helper type 17 survival and expansion in autoimmune disease. Nature Med. 2010; 16: 1917.
  • 14
    van Roon JA, Verweij MC, Wijk MW, et al . Increased intraarticular interleukin-7 in rheumatoid arthritis patients stimulates cell contact-dependent activation of CD4(+) T cells and macrophages. Arthritis Rheum. 2005; 52: 170010.
  • 15
    van Roon JA, Hartgring SA, Wenting-van Wijk M, et al . Persistence of interleukin 7 activity and levels on tumour necrosis factor alpha blockade in patients with rheumatoid arthritis. Ann Rheum Dis. 2007; 66: 6649.
  • 16
    Hartgring SA, van Roon JA, Wenting-van Wijk M, et al . Elevated expression of interleukin-7 receptor in inflamed joints mediates interleukin-7-induced immune activation in rheumatoid arthritis. Arthritis Rheum. 2009; 60: 2595605.
  • 17
    Faucher S, Crawley AM, Decker W, et al . Development of a quantitative bead capture assay for soluble IL-7 receptor alpha in human plasma. PLoS ONE. 2009; 4: e6690.
  • 18
    Rose T, Lambotte O, Pallier C, et al . Identification and biochemical characterization of human plasma soluble IL-7R: lower concentrations in HIV-1-infected patients. J Immunol. 2009; 182: 738997.